Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the post-surgical setting following orthopedic and soft tissue procedures along with Zynrelef's recent label expansion (January 2024) which will now cover an estimated 13 million procedures annually

Ticker(s): HRTX

Who's the expert?

Institution: The Orthopaedic & Fracture Clinic

Orthopaedic Surgeon specializing in Elbow, Hand & Wrist, Joint Replacement & Revision, and Orthopaedic Trauma.
Currently manages 800 patients with postoperative pain annually.
Familiar with Zynrelef's recent label expansion to include additional Orthopedic and Soft Tissue Procedures.

Interview Goal

The focus of this interview will focus on the post-surgical setting following orthopedic and soft tissue procedures along with Zynrelef's recent label expansion (January 2024) which will now cover an estimated 13 million procedures annually

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.